Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
04/2012
04/25/2012CN101573126B 选择性趋化因子调节 Selective regulation of chemokine
04/25/2012CN101524394B 雀嘴茶制剂及其应用 Sparrow mouth tea preparation and its application
04/25/2012CN101511831B 作为a2a受体激动剂的腺苷衍生物 As the derivatives of adenosine a2a agonist
04/25/2012CN101503457B 柱层析peg与干扰素类似物蛋白氮端定点偶联方法及其产物 Column chromatography peg interferon analog protein nitrogen end point coupling methods and their products
04/25/2012CN101456863B Novel LXR agonist as well as preparation method and application thereof
04/25/2012CN101417020B 具有散结消肿,化瘀止痛的药物组合物及制备方法和质量控制方法 Has Sanjie swelling, circulation and pain relief pharmaceutical composition and preparation methods, and quality control methods
04/25/2012CN101336985B 一种止痛止痒药酒及其制备方法 A wine and its preparation method itching and pain
04/25/2012CN101124220B 5-取代的喹啉和异喹啉衍生物、其制备方法及其作为抗炎药的用途 5-substituted quinoline and isoquinoline derivatives, their preparation and their use as anti-inflammatory agents
04/24/2012US8163806 Controlled release of biologically active compounds from multi-armed oligomers
04/24/2012US8163735 Sulfonamide compounds as cysteine protease inhibitors
04/24/2012US8163706 Method for preparing a centella asiatica extract rich in madecassoside and in terminoloside
04/24/2012US8163313 Compositions containing amines and use thereof
04/24/2012CA2641221C Method to predict and prevent oxygen-induced inflammatory tissue injury
04/24/2012CA2583589C Processes for preparing glatiramer
04/24/2012CA2573754C Substituted amino compounds as 5-ht/na uptake inhibitors
04/24/2012CA2481926C Heterocyclic compounds which inhibit leukocyte adhesion mediated by .alpha.4 integrins
04/24/2012CA2472582C Sterile filtered nanoparticulate formulations of budesonide and beclomethasone having tyloxapol as a surface stabilizer
04/24/2012CA2466036C Taste masking spill-resistant formulation
04/24/2012CA2452447C Antagonistic anti-htnfsf13b human antibodies
04/24/2012CA2433807C Hydrophobic polyamine analogs and methods for their use
04/24/2012CA2433582C Peptides having inhibiting activity on the production of nitric oxide
04/24/2012CA2408752C Delivery systems for treatment of vascular disease
04/19/2012WO2012051447A1 Targeted delivery of targeted exocytosis modulators to the sphenopalatine ganglion for treatment of headache disorders
04/19/2012WO2012051246A1 Tapentadol hydrobromide and crystalline forms thereof
04/19/2012WO2012051126A2 Anti-inflammatory macrolides
04/19/2012WO2012051111A2 Human oncostatin m antibodies and methods of use
04/19/2012WO2012050517A1 Imidazole substituted pyrimidine having a high gsk3 inhibiting potency as well as pan-kinase selectivity
04/19/2012WO2012050162A1 Cellular life span extending agent, and telomerase activator
04/19/2012WO2012050159A1 Amide derivative and use thereof
04/19/2012WO2012050154A1 Inhibitor of osteoclast formation containing anti-vdac antibody
04/19/2012WO2012049555A1 Spirocyclic compounds as voltage-gated sodium channel modulators
04/19/2012WO2012049550A1 Liquid pharmaceutical composition for pain treatment and prevention
04/19/2012WO2012049277A1 Cxcr4 receptor antagonists
04/19/2012WO2011163308A3 Compositions and methods for preventing and treating organ injury and/or dysfunction
04/19/2012WO2011159976A3 Arthritis treatment
04/19/2012WO2011159970A3 Method for predicting a therapy response in subjects with multiple sclerosis
04/19/2012WO2011153502A3 Anti-inflammatory and quorum sensing inhibition compounds and methods of making and using them
04/19/2012WO2011153331A3 Optical sensor conjugates for detecting reactive oxygen and/or reactive nitrogen species in vivo
04/19/2012WO2011149881A3 Methods for the treatment and prevention of inflammatory diseases
04/19/2012WO2011149766A3 Lipid-tailored pharmaceutical agents
04/19/2012WO2011149301A3 A composition comprising the extract of physalis alkekengi var. francheti hort as an active ingredient for preventing and treating inflammatory diseases
04/19/2012WO2011149288A3 Anti-inflammatory compound having inhibitory activity against multiple tyrosine kinases, and pharmaceutical composition containing same
04/19/2012WO2011146922A3 Materials and methods for treatment of inflammation
04/19/2012US20120096569 Anti-il-6 antibodies,compositions, methods and uses
04/19/2012US20120095418 Self-Supporting Films For Delivery Of Therapeutic Agents
04/19/2012US20120095102 Salts of 3-Pentylphenylacetic Acid and Pharmaceutical Uses Thereof
04/19/2012US20120095101 Aqueous intraocular penetration-promoting eye drop
04/19/2012US20120095096 2-oxamide inhibitors of phospholipase a2 activity and cellular arachidonate release based on dipeptides and pseudopeptides
04/19/2012US20120095095 Use of an omega-3 lipid-based emulsion following ischemic injury to provide protection and recovery in human organs
04/19/2012US20120095087 Enhanced products by sustainable processes for medicinal use
04/19/2012US20120095081 Treatment of paraoxonase 1 (pon1) related diseases by inhibition of natural antisense transcript to pon1
04/19/2012US20120095065 Macrocyclic compounds and methods of treatment
04/19/2012US20120095062 Tricyclic compounds, compositions, and methods
04/19/2012US20120095056 2,5-disubstituted tetrazole derivatives and their use as nicotinic acetylcholine receptor modulators
04/19/2012US20120095055 HEXAHYDROCYCLOPENTYL[f]INDAZOLE 5-HYDROXYMETHYL ETHANOLS AND DERIVATIVES THEREOF AS SELECTIVE GLUCOCORTICOID RECEPTOR MODULATORS
04/19/2012US20120095049 Nociceptin analogs
04/19/2012US20120095047 Novel Heteropyrrole Analogs Acting on Cannabinoid Receptors
04/19/2012US20120095046 Amido-Isothiazole Compounds and Their Use as Inhibitors of 11Beta-HSD1 for the Treatment of Metabolic Syndrome and Related Disorders
04/19/2012US20120095040 Cyclopenta[c]pyrrole-2-carboxylate derivatives, preparation thereof and therapeutic use thereof
04/19/2012US20120095033 Selective Glycosidase Inhibitors and Uses Thereof
04/19/2012US20120095025 SUBSTITUTED [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS
04/19/2012US20120095024 Toluidine sulfonamides and their use
04/19/2012US20120095020 Cathepsin S Inhibitor Compounds
04/19/2012US20120095012 Toluidine sulfonamides and their use
04/19/2012US20120095010 Tricyclic delta-opioid modulators
04/19/2012US20120095006 Treatment of pulmonary hypertension
04/19/2012US20120095005 Fused Bicyclic Pyrazole Derivatives As Kinase Inhibitors
04/19/2012US20120095003 Methods of using prodrugs of methyl hydrogen fumarate and pharmaceutical compositions thereof
04/19/2012US20120095002 Isoxazole-5-carboxamide derivatives
04/19/2012US20120095000 Compounds for activating tgf-beta signaling
04/19/2012US20120094996 Imidazo [2, 1-B] [1, 3, 4] Thiadiazole Derivatives
04/19/2012US20120094990 Phenylacetic acid compound
04/19/2012US20120094979 Thiazole or thiadizaloe derivatives for use as sphingosine 1-phosphate 1 (s1p1) receptor agonists
04/19/2012US20120094976 New chemical compounds
04/19/2012US20120094975 Pyrido [5, 4-d] pyrimidines as cell proliferation inhibitors
04/19/2012US20120094972 Heterocyclic compounds and their uses
04/19/2012US20120094971 Compositions Including 6-Aminohexanoic Acid Derivatives As HDAC Inhibitors
04/19/2012US20120094970 NON-HORMONAL STEROID MODULATORS OF NF-kB FOR TREATMENT OF DISEASE
04/19/2012US20120094966 Organic compounds
04/19/2012US20120094964 Sulfamoyl benzoic acid derivatives as trpm8 antagonists
04/19/2012US20120094963 Targeting prodrugs and compositions for the treatment of gastrointestinal diseases
04/19/2012US20120094962 Pharmaceutical composition for use in medical and veterinary ophthalmology
04/19/2012US20120094957 Inhibitors of fatty acid amide hydrolase
04/19/2012US20120094945 Discovery of Selective Glucocorticoid Receptor Modulators by Multiplexed Reporter Screening
04/19/2012US20120094944 Novel imidazopyridine compound
04/19/2012US20120094943 Alpha 7 nicotinic receptor selective ligands
04/19/2012US20120094938 Small Peptides And Methods For Treatment Of Chronic Inflammatory Bowel Disease
04/19/2012US20120094935 Methods for creating or identifying compounds that bind tumor necrosis factor alpha
04/19/2012US20120094934 Treatment of tumor necrosis factor receptor 2 (tnfr2) related diseases by inhibition of natural antisense transcript to tnfr2
04/19/2012US20120094933 Derivatives of apf and methods of use
04/19/2012US20120094932 Macrocyclic lactone compounds and methods for their use
04/19/2012US20120094931 Compositions and methods to modulate progression and onset of inflammatory bowel disease
04/19/2012US20120094918 Method of using diketopiperazines and composition containing them
04/19/2012US20120094911 Endokinin c/d-derived peptides
04/19/2012US20120094904 Fad4, fad5, fad5-2, and fad6, novel fatty acid desaturase family members and uses thereof
04/19/2012US20120094895 Method for enhancing phagocytosis of phosphatidylserine-exposing cells
04/19/2012US20120094893 Method of using diketopiperazines and composition containing them
04/19/2012US20120093938 Orally disintegrating tablets comprising diphenhydramine
04/19/2012US20120093936 Method and device for treatment of conditions associated with inflammation or undesirable activation of the immune system
04/19/2012US20120093931 Inhibition of Neovascularization by Cerium Oxide Nanoparticles
1 ... 194 195 196 197 198 199 200 201 202 203 204 205 206 207 208 209 210 211 212 213 214 ... 1272